Part III: Novel checkpoint kinase 2 (Chk2) inhibitors; design, synthesis and biological evaluation of pyrimidine-benzimidazole conjugates.
Galal SA, Khattab M, Shouman SA, Ramadan R, Kandil OM, Kandil OM, Tabll A, El Abd YS, El-Shenawy R, Attia YM, El-Rashedy AA, El Diwani HI.
Galal SA, et al. Among authors: el rashedy aa, el diwani hi, el abd ys, el shenawy r.
Eur J Med Chem. 2018 Feb 25;146:687-708. doi: 10.1016/j.ejmech.2018.01.072. Epub 2018 Feb 2.
Eur J Med Chem. 2018.
PMID: 29407991